{"id":"https://openalex.org/W7224880903","doi":"https://doi.org/10.3389/fphar.2026.1964162","title":"Comparison of subcutaneous and intravenous administration of the monoclonal antibody CSX-1004 on fentanyl-induced respiratory depression in squirrel monkeys","display_name":"Comparison of subcutaneous and intravenous administration of the monoclonal antibody CSX-1004 on fentanyl-induced respiratory depression in squirrel monkeys","publication_year":2026,"publication_date":"2026-10-30","ids":{"openalex":"https://openalex.org/W7224880903","doi":"https://doi.org/10.3389/fphar.2026.1964162"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1964162","doi":"https://doi.org/10.3389/fphar.2026.1964162","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1964162","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1964162/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1964162/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062928344","display_name":"Mukesh Kumar","orcid":"https://orcid.org/0009-0008-1702-4064","observed_orcids":["https://orcid.org/0009-0008-1702-4064"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801148111","display_name":"McLean Hospital","ror":"https://ror.org/01kta7d96","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801148111"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mukesh Kumar","raw_affiliation_strings":["Department of Psychiatry, Harvard Medical School","Integrative Neurochemistry Laboratory, Behavioral Biology Program, McLean Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Harvard Medical School","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Integrative Neurochemistry Laboratory, Behavioral Biology Program, McLean Hospital","institution_ids":["https://openalex.org/I2801148111"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062743723","display_name":"Emily L. Burke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801148111","display_name":"McLean Hospital","ror":"https://ror.org/01kta7d96","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801148111"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily L. Burke","raw_affiliation_strings":["Department of Psychiatry, Harvard Medical School","Integrative Neurochemistry Laboratory, Behavioral Biology Program, McLean Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Harvard Medical School","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Integrative Neurochemistry Laboratory, Behavioral Biology Program, McLean Hospital","institution_ids":["https://openalex.org/I2801148111"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153410259","display_name":"Yanan Zang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yanan Zang","raw_affiliation_strings":["Department of Pharmaceutics, College of Pharmacy, University of Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, College of Pharmacy, University of Florida","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159252832","display_name":"Abhisheak Sharma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abhisheak Sharma","raw_affiliation_strings":["Department of Pharmaceutics, College of Pharmacy, University of Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, College of Pharmacy, University of Florida","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072582179","display_name":"Paul T. Bremer","orcid":"https://orcid.org/0000-0002-8357-1743","observed_orcids":["https://orcid.org/0000-0002-8357-1743"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul T. Bremer","raw_affiliation_strings":["Cessation Therapeutics, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cessation Therapeutics, Inc","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031837846","display_name":"Rajeev I. Desai","orcid":"https://orcid.org/0000-0002-4053-5996","observed_orcids":["https://orcid.org/0000-0002-4053-5996"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801148111","display_name":"McLean Hospital","ror":"https://ror.org/01kta7d96","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801148111"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rajeev I. Desai","raw_affiliation_strings":["Department of Psychiatry, Harvard Medical School","Integrative Neurochemistry Laboratory, Behavioral Biology Program, McLean Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Harvard Medical School","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Integrative Neurochemistry Laboratory, Behavioral Biology Program, McLean Hospital","institution_ids":["https://openalex.org/I2801148111"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5031837846"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I2801148111"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.84871154,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.35600000619888306,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.35600000619888306,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.3100999891757965,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11635","display_name":"Poisoning and overdose treatments","score":0.050999999046325684,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fentanyl","display_name":"fentanyl","score":0.6840000152587891},{"id":"https://openalex.org/keywords/opioid-induced-respiratory-depression","display_name":"opioid-induced respiratory depression","score":0.9160000085830688},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9089999794960022},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.9380000233650208},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.9990000128746033},{"id":"https://openalex.org/keywords/route-of-administration-comparison","display_name":"route of administration comparison","score":0.6830000281333923},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9700000286102295},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9769999980926514},{"id":"https://openalex.org/keywords/population-pharmacokinetic-model","display_name":"population pharmacokinetic model","score":0.8650000095367432},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.8529999852180481},{"id":"https://openalex.org/keywords/respiratory-protection","display_name":"respiratory protection","score":0.45899999141693115},{"id":"https://openalex.org/keywords/drug-overdose-deaths","display_name":"drug overdose deaths","score":0.47699999809265137},{"id":"https://openalex.org/keywords/squirrel-monkey","display_name":"squirrel monkey","score":0.6029999852180481}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8295000195503235},{"id":"https://openalex.org/C534529494","wikidata":"https://www.wikidata.org/wiki/Q7891","display_name":"Respiratory system","level":2,"score":0.6639999747276306},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.659500002861023},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.6158000230789185},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6068000197410583},{"id":"https://openalex.org/C2781072394","wikidata":"https://www.wikidata.org/wiki/Q407541","display_name":"Fentanyl","level":2,"score":0.5098999738693237},{"id":"https://openalex.org/C125287762","wikidata":"https://www.wikidata.org/wiki/Q1758948","display_name":"Absorption (acoustics)","level":2,"score":0.4401000142097473},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4108999967575073},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.38530001044273376},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.38339999318122864},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.3822000026702881},{"id":"https://openalex.org/C2776093070","wikidata":"https://www.wikidata.org/wiki/Q621636","display_name":"Route of administration","level":2,"score":0.3734999895095825},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.36899998784065247},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3508000075817108},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.3481999933719635},{"id":"https://openalex.org/C2776178081","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Respiratory disease","level":3,"score":0.3434000015258789},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.3061000108718872},{"id":"https://openalex.org/C2779350572","wikidata":"https://www.wikidata.org/wiki/Q784720","display_name":"Sublingual administration","level":2,"score":0.27709999680519104},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2711000144481659},{"id":"https://openalex.org/C2776390293","wikidata":"https://www.wikidata.org/wiki/Q2035485","display_name":"Subcutaneous injection","level":2,"score":0.2671000063419342},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.2655999958515167}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.3389/fphar.2026.1964162","doi":"https://doi.org/10.3389/fphar.2026.1964162","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1964162","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1964162/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:0858c63df47c44f8a477a652929a6302","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/0858c63df47c44f8a477a652929a6302","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1964162","doi":"https://doi.org/10.3389/fphar.2026.1964162","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1964162","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1964162/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7224880903.pdf","grobid_xml":"https://content.openalex.org/works/W7224880903.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W1596437242","https://openalex.org/W1987625267","https://openalex.org/W2035387023","https://openalex.org/W2061229586","https://openalex.org/W2771307521","https://openalex.org/W2883052264","https://openalex.org/W2884345284","https://openalex.org/W2903520456","https://openalex.org/W2921971750","https://openalex.org/W2923555790","https://openalex.org/W2949192028","https://openalex.org/W2951609968","https://openalex.org/W3033386824","https://openalex.org/W3042777354","https://openalex.org/W3088839269","https://openalex.org/W3210758715","https://openalex.org/W4213099197","https://openalex.org/W4301185386","https://openalex.org/W4368360134","https://openalex.org/W4376873082","https://openalex.org/W4387296292","https://openalex.org/W4389333921","https://openalex.org/W4389740232","https://openalex.org/W4392236366","https://openalex.org/W4393385783","https://openalex.org/W4407182820","https://openalex.org/W4411306845","https://openalex.org/W4415030058","https://openalex.org/W7127055530","https://openalex.org/W7162448813"],"related_works":["https://openalex.org/W4377020838","https://openalex.org/W4389333921","https://openalex.org/W4390790985","https://openalex.org/W4377029127","https://openalex.org/W7160861109","https://openalex.org/W4415030058","https://openalex.org/W4407182820","https://openalex.org/W4416612826","https://openalex.org/W2051286238","https://openalex.org/W3170923057"],"abstract_inverted_index":{"Background":[0],"Fentanyl":[1],"and":[2,32,45,52,61,101,108,114,119,164,194,201,208,228,238,249,271,288],"related":[3],"synthetic":[4],"opioids":[5],"remain":[6],"major":[7],"contributors":[8],"to":[9,25,68,141,275],"overdose":[10],"mortality,":[11],"primarily":[12],"through":[13,257],"opioid-induced":[14],"respiratory":[15,76,124,209,255,297],"depression.":[16,298],"CSX-1004":[17,57,85,145,268],"is":[18,280],"a":[19,63,128,148,286],"fully":[20],"human":[21],"monoclonal":[22],"antibody":[23,93],"designed":[24],"bind":[26],"fentanyl":[27,135],"in":[28,58,127,134],"the":[29,37,42,198,220,225,246],"peripheral":[30],"circulation":[31],"prevent":[33],"its":[34],"entry":[35],"into":[36],"brain.":[38],"This":[39],"study":[40],"evaluated":[41],"pharmacokinetic":[43],"(PK)":[44],"pharmacodynamic":[46],"(PD)":[47],"equivalence":[48],"of":[49,56,82,122,151,168,267],"intravenous":[50],"(IV)":[51],"subcutaneous":[53],"(SC)":[54],"administration":[55,81,116,146,218,240,266],"squirrel":[59],"monkeys":[60],"established":[62],"population":[64],"PK":[65,102,270],"(PopPK)":[66],"model":[67,190],"support":[69],"route":[70],"extrapolation.":[71],"Methods":[72],"Protection":[73],"against":[74,295],"fentanyl-induced":[75,123,296],"depression":[77],"was":[78,181],"assessed":[79],"after":[80,213,216],"40":[83],"mg/kg":[84],"using":[86,106],"whole-body":[87],"plethysmography":[88],"over":[89],"28":[90,142],"days.":[91,143],"Serum":[92,206],"concentrations":[94,207,251],"were":[95,104,211],"quantified":[96],"by":[97],"enzyme-linked":[98],"immunosorbent":[99],"assay,":[100],"parameters":[103],"characterized":[105],"noncompartmental":[107],"PopPK":[109,189],"analyses.":[110],"Results":[111],"Both":[112],"IV":[113,217,239,276],"SC":[115,144,214,237,265,283],"produced":[117],"substantial":[118],"durable":[120],"attenuation":[121],"depression,":[125],"resulting":[126],"greater":[129],"than":[130,215],"10-fold":[131],"rightward":[132],"shift":[133],"potency":[136],"that":[137,236,264],"persisted":[138],"for":[139,292],"up":[140],"exhibited":[147],"maximum":[149],"concentration":[150],"491.7":[152],"\u00b1":[153,158],"50.4":[154],"\u03bcg/mL":[155],"at":[156],"48.0":[157],"19.6":[159],"h":[160],"(T":[161],"max":[162],")":[163],"an":[165],"absolute":[166],"bioavailability":[167],"92.0%":[169],"based":[170],"on":[171],"A":[172,187],"U":[173],"C":[174],"0":[175],"\u2212":[176],"\u221e":[177],".":[178],"Terminal":[179],"half-life":[180],"comparable":[182,274],"between":[183],"routes":[184],"(\u223c272":[185],"h).":[186],"two-compartment":[188],"with":[191,253],"first-order":[192],"absorption":[193,226,247,279],"elimination":[195],"adequately":[196],"described":[197],"concentration\u2013time":[199],"data":[200],"demonstrated":[202],"robust":[203],"predictive":[204],"performance.":[205],"protection":[210,256],"lower":[212],"during":[219],"first":[221],"24\u201348":[222],"h,":[223],"reflecting":[224],"phase,":[227],"converged":[229],"from":[230],"Day":[231,258],"2":[232],"onward.":[233],"Simulations":[234],"indicated":[235],"achieved":[241],"overlapping":[242],"systemic":[243],"exposures":[244],"beyond":[245],"phase":[248],"equivalent":[250],"associated":[252],"sustained":[254],"28.":[259],"Conclusion":[260],"These":[261],"findings":[262],"demonstrate":[263],"provides":[269],"PD":[272],"outcomes":[273],"dosing,":[277],"once":[278],"complete,":[281],"supporting":[282],"delivery":[284],"as":[285],"practical":[287],"clinically":[289],"feasible":[290],"approach":[291],"long-acting":[293],"prophylaxis":[294]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2026-10-31T00:00:00"}